Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study

2019 ◽  
Author(s):  
Monica Gadelha ◽  
Annamaria Colao ◽  
Marie Bex ◽  
Rishav Mukherjee ◽  
Catherine Bourad ◽  
...  
Keyword(s):  
First Generation ◽  
Somatostatin Analogues ◽  
Biochemical Control ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Long Acting

P.3.c.011 Olanzapine long-acting injection vs oral olanzapine in schizophrenia outpatients: a 2-year, randomized, open-label study

2010 ◽  
Vol 20 ◽  
pp. S464 ◽  
Author(s):  
H. Detke ◽  
P.J. Weiden ◽  
T. Lambert ◽  
P.M. Llorca ◽  
M. Choukour ◽  
...  
Keyword(s):  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Oral Olanzapine ◽  
Long Acting

A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea

2014 ◽  
Vol 29 (5) ◽  
pp. 279-287 ◽  
Author(s):  
Nam Young Lee ◽  
Se Hyun Kim ◽  
Seong Jin Cho ◽  
Young-Cho Chung ◽  
In Kwa Jung ◽  
...  
Keyword(s):  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Symptomatic Remission ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document